These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11805720)

  • 1. Factors associated with long-term renal allograft survival.
    Kaplan B; Srinivas TR; Meier-Kriesche HU
    Ther Drug Monit; 2002 Feb; 24(1):36-9. PubMed ID: 11805720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of age on rejection in kidney transplantation.
    de Fijter JW
    Drugs Aging; 2005; 22(5):433-49. PubMed ID: 15903355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for minimization strategies: current problems of immunosuppression.
    Bamoulid J; Staeck O; Halleck F; Khadzhynov D; Brakemeier S; Dürr M; Budde K
    Transpl Int; 2015 Aug; 28(8):891-900. PubMed ID: 25752992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte markers and prediction of long-term renal allograft acceptance.
    Babel N; Reinke P; Volk HD
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):489-94. PubMed ID: 19724222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic renal allograft damage: existing challenges.
    Arias M; Serón D; Moreso F; Bestard O; Praga M
    Transplantation; 2011 May; 91(9 Suppl):S4-25. PubMed ID: 21519213
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic renal allograft failure: clinical overview. The Leuven Collaborative Group for Transplantation.
    Peeters J; Roels L; Vanrenterghem Y
    Kidney Int Suppl; 1995 Dec; 52():S97-101. PubMed ID: 8587294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term graft outcome of living donor renal transplantation: single center experience.
    Kwon OJ; Kim YH; Ahn BK; Kang CM; Kwak JY
    Transplant Proc; 2005 Mar; 37(2):690-2. PubMed ID: 15848503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from cyclosporine monotherapy in renal transplantation: the impact of acute rejection on long-term allograft outcome.
    Coll E; Crespo M; Solé M; Campistol JM; Cofàn F; Esforzado N; Ricart MJ; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2004 Mar; 36(2 Suppl):114S-116S. PubMed ID: 15041318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early graft dysfunction developed within one week after renal allograft.
    Kim SC; Jang HJ; Kim SK; Kim TH; Yoo ES; Jung JG; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1886-7. PubMed ID: 11119985
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
    Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo immunosuppressive effect of purine nucleoside phosphorylase inhibitor-8-amino-9-benzyl-guanine in canine renal allograft rejection.
    Lin CY; Yen CY
    Transplant Proc; 1994 Dec; 26(6):3126-7. PubMed ID: 7998091
    [No Abstract]   [Full Text] [Related]  

  • 16. New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients.
    Sommerer C; Giese T; Meuer S; Zeier M
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1030-7. PubMed ID: 21060169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil improves long-term graft survival following renal transplantation in patients experiencing delayed graft function. International Mycophenolate Mofetil Renal Study Groups.
    Cho S; Hodge E; Navarro M
    Transplant Proc; 1999; 31(1-2):322-3. PubMed ID: 10083126
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in immunosuppressive therapy for prevention of renal allograft rejection.
    Lunsford KE; Barbas AS; Brennan TV
    Curr Opin Organ Transplant; 2011 Aug; 16(4):390-7. PubMed ID: 21666473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts and perspectives of immunosuppression in organ transplantation.
    Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
    Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.